Fred Saad, ESMO 2022: Phase IIIPROpel trial of abiraterone+olaparib in prostate cancer from olaparib prostate cancer results Watch Video
Preview(s):
Gallery
Gallery
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 4 minutes 56 seconds 👁 View: 196 times
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)